1 July 2025 | 3:48PM HKT China Healthcare Service & Devices CDMO 2Q order momentum continued; recovery for Medtech & Services more likely in 2H25 We hosted 54 China Healthcare companies in-person in Hong Kong (June 24-27), among which were CDMO/CRO (e.g., WuXi AppTec, Asymchem, Pharmaron, WuXi XDC, Tigermed, Genscript, Bora Pharma), MedTech (Weigao, AK Medical, Kangji, Angelalign, Jiangsu Yuyue, and Lepu), and Service names (Hygiea, Gushengtang, Jinxin, Aier). CRO/CDMO: Momentum continues; investor focus on ...

When firms raise prices, “gouging” their customers, many governments complain. Some cannot resist intervening. But in today’s China, the opposite is happening https://t.co/lsmb8L5bOPIllustration: Alex Nabaum https://t.co/XifKWqMktp ...

Why is the story of the Monkey King still so popular—and what does it reveal about China today? Listen to “Drum Tower”, with Jiehao Chen and @RosieBlau https://t.co/vQunVe4DZc ...

June 30, 2025 02:51 AM GMT Retail & Internet | North America Temu Survey: Further Slippage Latest AlphaWise and 3P data indicates policy changes continue to impact Temu demand. Household purchases are at a nadir, purchase expectations trail competitors, and 3P data shows declines. Dollar Stores stand to be the biggest beneficiaries, though the policy environment is still uncertain. M This is our tenth Temu usage/adoption survey note following our deep dive. Demand for Temu continued to decline in June, indi ...

June 30, 2025 01:16 AM GMT Investor Presentation | Asia Pacific M Foundation China Economics: Solid 2Q, Softening Momentum, Fall Stimulus Likely Related Reports: Solid 2Q, Softening Momentum, Fall Stimulus Likely (26 June 2025) Morgan Stanley Asia Limited Robin Xing Chief China Economist Robin.Xing@morganstanley.com +852 2848-6511 Zhipeng Cai Economist Zhipeng.Cai@morganstanley.com +852 2239-7820 For important disclosures, refer to the Disclosure Section, located at the end of this report. M Fall Stimulus S ...

Decoding China's Industrial Policy – Prof Fang and team analysed c. 3 million separate policy documents issued from various levels of government (central, provincial, cities, counties, etc). The three main questions they sought to answer were; The availability of LLMs (large language models) and sophisticated engineering allowed an analysis in detail which would not have been possible two years ago. Only 30% of policy documents were issued by central government – Across the 3m documents, c. 26% were explici ...

ASIA-PACIFIC excl. Japan | Industrials Equity Research Alpha Signals in China's Fragile Recovery China's manufacturing is undergoing a complex transition shaped by domestic consumption shifts, global trade dynamics, and technology innovation. We summarize our insights from recent field research across the YRD region, by answering the questions on recent demand momentum domestically and globally, as well as the alpha opportunities we've seen from differentiation, globalization, import substitution and new ec ...

June 25, 2025 02:20 AM GMT Investor Presentation | Japan Semiconductor Production Equipment: Tech Monthly June 2025 M Foundation Morgan Stanley MUFG Securities Co., Ltd.+ Tetsuya Wadaki Equity Analyst Tetsuya.Wadaki@morganstanleymufg.com +81 3 6836-8890 Semiconductor Production Equipment Japan Industry View Attractive Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could ...

25 June 2025 Equity Research Report China Consumer Equities 2H25 outlook: Will 'old' and 'new' consumption continue to diverge? What's different in 1H25 from our expectations: In our 2025 annual outlook report, we listed three investment themes for the year: (1) policy beneficiaries; (2) market share gains; and (3) an improving industry outlook with higher yield (China Consumer: 2025 outlook: Green shoots to emerge, 22 November 2024). We noted (1) slower- than-expected launch of consumption stimulus policie ...

Government Intervention - Governments often complain and intervene when firms raise prices, accusing them of "gouging" customers [1] - In China, the opposite situation of price gouging is currently occurring [1]